Moore Capital Management, LP Senseonics Holdings, Inc. Transaction History

Moore Capital Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$2.3 - $3.27 $229,999 - $327,000	-100,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$3.4 - $4.84 $255,000 - $363,000	-75,000 Reduced 42.86%	100,000 $477,000
Q2 2018 Aug 14, 2018	BUY	$3.03 - $4.98 $530,250 - $871,500	175,000 New	175,000 $719,000

142

60.1M

413K

212K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $154M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.